• 25-Hydroxycholesterol Drives Immunosuppressive Macrophage Re

  2026-05-28

  Xiao et al. (2024) identify lysosomal 25-hydroxycholesterol (25HC) as a pivotal regulator of tumor-associated macrophage (TAM) immunosuppressive function via AMPKα activation and STAT6 phosphorylation. Their findings reveal CH25H as an immunometabolic checkpoint and suggest targeting this axis can potentiate anti-tumor immunity, including in combination with anti-PD-1 therapy.

• Super-Enhancer RNA Drives NPC Metastasis via NPM1/c-Myc/NDRG

  2026-05-27

  This study elucidates how exposure to the carcinogen DNP induces a specific super-enhancer RNA (seRNA-NPCm), which in turn drives metastasis in nasopharyngeal carcinoma (NPC) by modulating the NPM1/c-Myc/NDRG1 axis. These findings provide mechanistic insights into enhancer RNA function in cancer progression and point toward new molecular targets for prognosis and intervention.

• CCK-8 in Translational Neuroscience: Mechanisms, Metrics, an

  2026-05-27

  This thought-leadership article explores the mechanistic foundations and strategic applications of the Cell Counting Kit-8 (CCK-8) for translational researchers, focusing on its pivotal role in advancing cell viability and proliferation assays within neurodevelopmental and cancer research. By anchoring the discussion in recent evidence from ASD cellular models and integrating competitive insights, the article offers actionable guidance and a visionary outlook on assay optimization.

• CGP 55845 Hydrochloride: Optimizing GABAB Antagonist Assays

  2026-05-26

  CGP 55845 hydrochloride, a potent GABAB receptor antagonist, is revolutionizing in vitro synaptic transmission research. This guide translates recent astrocyte-focused breakthroughs into actionable workflows, comparative advantages, and troubleshooting strategies for advanced neurotransmitter modulation studies.

• Streptavidin-Cy3: Precision Biotin Detection in Metastasis R

  2026-05-26

  Streptavidin-Cy3 enables ultra-sensitive, quantitative visualization of biotinylated targets in advanced oncology and super-enhancer biology. By integrating robust fluorescence with steadfast biotin affinity, this conjugate empowers researchers to dissect metastatic pathways and optimize immunofluorescence workflows with unmatched clarity.

• Puromycin dihydrochloride: Precision Selection and Assay Mas

  2026-05-25

  Puromycin dihydrochloride, a potent aminonucleoside antibiotic, empowers robust cell selection and nuanced translational studies from angiogenesis to apoptosis. Leverage its versatility for stable cell line establishment, ribosome function analysis, and troubleshooting of protein synthesis assays with data-backed optimizations.

• Sulfaphenazole: Elevating CYP2C9 Inhibition in Translational

  2026-05-25

  This thought-leadership article unpacks the mechanistic foundation and strategic value of Sulfaphenazole as a selective CYP2C9 inhibitor. We synthesize recent advances in antibacterial and vascular research, address translational challenges, and offer expert guidance on experimental protocols and future directions, drawing on reference studies and APExBIO product intelligence.

• Streptavidin-Cy3 (SKU K1079): Precision Biotin Detection in

  2026-05-24

  This in-depth guide addresses real-world laboratory challenges in cell viability, proliferation, and cytotoxicity workflows, demonstrating how Streptavidin-Cy3 (SKU K1079) from APExBIO delivers reproducibility and high sensitivity for biotin detection. Integrating scenario-driven Q&As, literature insight, and protocol optimization, the article empowers researchers to streamline immunohistochemistry, immunofluorescence, and flow cytometry assays with validated best practices.

• MG-132 (Z-LLL-al): Advancing Proteasome Inhibition in Genome

  2026-05-23

  Explore how MG-132, a potent proteasome inhibitor, is transforming genome stability assays and the study of nuclear cGAS-mediated retrotransposon repression. Uncover advanced applications and protocol insights distinct from existing guides.

• Super-Enhancer RNA Drives NPC Metastasis via NPM1/c-Myc/NDRG

  2026-05-22

  This study reveals that a carcinogen-induced super-enhancer RNA (seRNA-NPCm) promotes metastasis in nasopharyngeal carcinoma (NPC) by orchestrating NDRG1 gene activation through the NPM1/c-Myc pathway. These findings uncover a new regulatory mechanism in NPC progression and highlight potential molecular targets for future research and prognosis.

• Bradykinin for Endothelium-Dependent Vasodilator Research

  2026-05-22

  Bradykinin (SKU BA5201) is a rigorously defined endothelium-dependent vasodilator peptide intended for applications in vascular permeability, smooth muscle contraction, pain mechanism, and inflammation signaling research. This product addresses the need for precise, reproducible modulation of vascular and nonvascular tissue responses in controlled experimental settings. It is not suitable for diagnostic or therapeutic applications, nor for use in protocols requiring long-term stock storage.

• 25-Hydroxycholesterol Drives Immunosuppressive Macrophage Re

  2026-05-21

  Xiao et al. (2024) uncover how 25-hydroxycholesterol (25HC) accumulates in tumor-associated macrophages (TAMs) and reprograms their metabolic pathways to reinforce immunosuppression. By elucidating the lysosomal signaling axis involving CH25H, AMPKα, and STAT6, the study offers new insight into manipulating the tumor immune microenvironment and highlights potential targets for improving cancer immunotherapy.

• Naftifine HCl: Advanced Mechanistic Insights and Translation

  2026-05-21

  Explore Naftifine HCl, an advanced allylamine antifungal agent, with a focus on its unique squalene epoxidase inhibition, translational assay decisions, and muscle signaling cross-talk. Discover protocol guidance and novel research perspectives distinct from existing content.

• EZ Cap™ Mouse IL-12 mRNA (m1Ψ): Precision Cytokine mRNA Plat

  2026-05-20

  EZ Cap™ Mouse IL-12 mRNA (m1Ψ) delivers stabilized, low-immunogenicity mouse Interleukin-12 mRNA for advanced immunotherapy research. The product’s Cap 1 structure and m1Ψ modification enhance stability and translational efficiency while minimizing innate immune activation. This article details the biological rationale, mechanism, benchmarks, and common pitfalls for optimal research use.

• CB-5083: Advanced p97 Inhibitor Protocols for Oncology Resea

  2026-05-20

  CB-5083 empowers researchers to dissect p97-dependent protein homeostasis disruption and apoptosis in cancer cells with precision. This article details robust workflows, experimental nuances, and troubleshooting insights for maximizing CB-5083’s impact in translational oncology.

408 records 7/28 page Previous Next First page 上5页 678910 下5页 Last page